SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that it plans to report second quarter 2008 financial results on Thursday, July 31, 2008, following the close of market. Ligand’s President and CEO, John L. Higgins, Vice President of Finance and CFO, John P. Sharp and Vice President of Discovery Research, Dr. Martin Meglasson will host the conference call.
